SEC Filing

Investor Contacts

Katherine A. Littrell, PhD, RN
Vice President, Investor Relations

Diane H. Schrick
Senior Director, Investor Relations

investorinfo@jazzpharma.com
Ireland: +353 1 634 7892
U.S.: +1 650 496 2800

SEC Filing Details

Document Details

Form
Filing Date
Mar 9, 2007
Document Date
Mar 9, 2007
Form Description
Registration statement for face-amount certificate companies
Filing Group
Registration Statements
Company
Jazz Pharmaceuticals plc
Issuer
Jazz Pharmaceuticals plc